CarlosCarlos Martínez-Salgado, PhD
, has a Degree and a Doctorate with Honours in Biology (University of Salamanca, 1999). From 2000 to 2002 he conducted a 3-year postdoctoral training at the Max-Delbrück-Centrum in Berlin, Germany, funded by a grant from the European Marie-Curie program. He returned to the University Hospital of Salamanca in 2003 and since then he has established a translational research group focused on the study of chronic kidney disease and cardiovascular and renal damage associated with hypertension and diabetes. He also obtained a position as Associate Professor of Physiology in the Faculty of Medicine, University of Salamanca. Since 2011, his group belongs to the Institute of Biomedical Research of Salamanca (IBSAL). The research group is a member of the Spanish National Network for Renal Diseases (REDinREN), the European Renal Association (ERA-EDTA), and the European Society of Translational Medicine (EUSTM). The group’s scientific research is sponsored by Spanish public institutions, such as the Carlos III Health Institute and other ministerial agencies. The current interests of the group are the study of mechanisms, mediators and receptors involved in the pathophysiology of fibrosis leading to renal and cardiovascular damage, and the search for effective prognostic and diagnostic biological markers of these damages.


Linkedin Page

Ana I. Morales, PhDAna I. Morales, PhD, has a Degree and a Doctorate with Honors in Pharmacy (University of Salamanca, 1995). She is a specialist in Hospital Pharmacy. Currently Dr. Morales is Professor of Toxicology and Vice-Dean of the School of Pharmacy. She is Director of the University of Salamanca Unit of Toxicology. Her resumé includes: Grants (32); Doctorate thesis supervisor (18); articles (40); books (5); patents (1); participation in national and international congresses (120); reviewer for 25 international journals and expert/project reviewer for national and international agencies. The aim of her research in recent years has been focused on improving the clinical management and prognosis of patients with acute renal failure due to nephrotoxicity of drugs and environmental pollutants.


FranLHFrancisco J. López-Hernández, PhD
, has a degree in Pharmacy (1993) and a doctorate in Physiology & Pharmacology (1997). He was visiting scientist at the University of Vermont (USA) in 1994, and at the University of Puerto Rico in 1993 and 1995. Dr. López-Hernandez spent 6 years in the Sidney Kimmel Cancer Center (San Diego, CA, USA) as a Post-doctoral Associate (1999-2004). From 2004 to 2005, he spent a year in the biotech industry. In 2005, he returned to academia, founding a translational research group in the University Hospital of Salamanca and becoming Associate Professor of Physiology in the University of Salamanca. Since then, his main interests have focused on understanding the pathophysiological basis of acute kidney injury, and on developing innovative diagnostic and preventive tools. By 2012 his group was transferred to the Salamanca Biomedical Research Institute (IBSAL). In 2014 he was among the founders of the Group of Biomedical Research on Critical Care (BioCritic). In 2009 Dr. López-Hernández promoted the creation of a spin-off biotech company to further develop academic knowledge into clinical applications, where he now serves as Scientific Advisor. His group is a member of the National Network for Renal Diseases (RedinRen), sponsored by the Carlos III Health Institute, the European Kidney and Urinary Proteomics (EuroKUP) Group, the European Renal Association (ERA-EDTA), and the European Society of Translational Medicine (EUSTM). Dr. López-Hernandez has gained expertise in translational research, technology transfer and development through public-private partnerships and international initiatives.


LinkedIn Page



José Miguel López Novoa,

PhD, Full Professor of Physiology (retired)



DSC_0904copiaNélida Eleno Balboa,

PhD, Full Professor of Physiology.

Researcher responsible for the Recognized Research Group (Grupo de Investigación Reconocido, GIR) sponsored by the University of Salamanca (Spain)


DSC_0798copia Marta Prieto Vicente,

PhD, Professor of Toxicology

MPescador Moises Pescador Garriel,

PhD, Professor of Toxicology

IsaFCIsabel Fuentes Calvo,

PhD, Professor of Physiology

Laura Ramudo González,

PhD, Professor of Physiology

LVicente Laura Vicente Vicente,

PhD, Assistant Professor of Toxicology

dsc_0703copia Sandra M. Sancho Martínez,

PhD, Assistant Professor of Pharmacology

Yaremi Quirós Luis

PhD Researcher

Miguel Quintero Coca

PhD Researcher

VictorBG Víctor Blanco Gozalo,

PhD Researcher



DSC_0868copiaCristina Cuesta Apausa,

PhD Student


AlfredoCP Alfredo Ginés Casanova Paso,

PhD Student

Mª Teresa Hernández Sánchez,

PhD Student

Giampiero Andrea Masaro,

PhD Student

Maria Paniagua Sancho

PhD Student


Almudena Hernández Blázquez

Bart Stuert

David Orlando Paez Melo

Florence Costalas

José Antonio Duarte Conde

Mario de Juan Alberdi

Mónica Redondo Puente

Nahia Hernández Quitián

Omar A. Hidalgo Thomas

Paula Toral Soldevilla

Carlota Malvido Rodríguez


José Manuel Muñoz Félix


NuriaPerrettaNuria Perretta Tejedor,


LPrietoLaura Prieto García,


Alba Miguel Ayuso

Graduate student

Cristina Pizarro Sánchez

Graduate student

Francesco Alioto

Graduate student


Guadalupe Tabernero Fernández, MD, Nephrology Specialist

Pilar Fraile Gómez, MD, Nephrology Specialist

José Luis Lerma Marquez, MD, Nephrology Specialist

Elena Ruiz Ferreras, MD, Nephrology Specialist

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s